TY - JOUR
T1 - Interlaboratory Comparison of Hydrogen-Deuterium Exchange Mass Spectrometry Measurements of the Fab Fragment of NISTmAb
AU - Hudgens, Jeffrey W.
AU - Gallagher, Elyssia S.
AU - Karageorgos, Ioannis
AU - Anderson, Kyle W.
AU - Filliben, James J.
AU - Huang, Richard Y.C.
AU - Chen, Guodong
AU - Bou-Assaf, George M.
AU - Espada, Alfonso
AU - Chalmers, Michael J.
AU - Harguindey, Eduardo
AU - Zhang, Hui Min
AU - Walters, Benjamin T.
AU - Zhang, Jennifer
AU - Venable, John
AU - Steckler, Caitlin
AU - Park, Inhee
AU - Brock, Ansgar
AU - Lu, Xiaojun
AU - Pandey, Ratnesh
AU - Chandramohan, Arun
AU - Anand, Ganesh Srinivasan
AU - Nirudodhi, Sasidhar N.
AU - Sperry, Justin B.
AU - Rouse, Jason C.
AU - Carroll, James A.
AU - Rand, Kasper D.
AU - Leurs, Ulrike
AU - Weis, David D.
AU - Al-Naqshabandi, Mohammed A.
AU - Hageman, Tyler S.
AU - Deredge, Daniel
AU - Wintrode, Patrick L.
AU - Papanastasiou, Malvina
AU - Lambris, John D.
AU - Li, Sheng
AU - Urata, Sarah
N1 - Funding Information:
archival. J.W.H. also thanks Dr. Y. Hamuro for insightful discussions. I.K., E.S.G., and K.W.A. of NIST and IBBR acknowledge support from the NIST National Research Council (NRC) Postdoctoral Research Associateship Program. R.Y.C.H. and G.C. of Bristol-Myers Squibb acknowledge Dr. A. Tymiak and Dr. B. Car for their support of this project. A.E. and E.H. at Centro de Investigacioń Lilly, S.A., acknowledge Mr. S. Cano for technical assistance. H.M.Z., B.W., and J.Z. at Genentech, Inc. acknowledge Dr. Y.-H. Kao and Dr. J. Stults for their support for this project. X.L. and R.P. of MedImmune LLC acknowledge Dr. Q. (Paula) Lei and Dr. M. Washabaugh for their support for this study. D.D.W. at Univ. of Kansas acknowledges Agilent Technologies for an equipment loan.
Funding Information:
⬠Broad Institute of MIT & Harvard, 415 Main Street, Cambridge, MA 02142, United States. E-mail: malpap@ broadinstitute.org. ⬣E-mail: sarah.urata@gmail.com. Author Contributions ⊕These authors contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. Funding The NIST project (design, test reagents, data analysis, and manuscript preparation) was funded by the NIST Biomanfactur-ing Program, and the project design precludes the presence of competing financial interests. C.S. was supported by the National Institute of General Medical Sciences of the National Institutes of Health (NIH), Award No. U54 GM094586. G.S.A. was supported by grants from the Singapore Ministry of Education Academic Research Fund Tier 3 (No. MOE2012-T3-1-008). K.D.R. acknowledges financial support from the Danish Council for Independent Research (Sapere Aude Grant No. DFF-4184-00537A). D.D. and P.W. declare that work at their institution was supported in part by the Univ. of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014). M.P. and J.D.L. declare that work conducted at their institution was supported by National Institutes of Health (Grant Nos. AI068730 and AI030040). Notes Disclaimer: Certain commercial materials and equipment are identified to adequately specify experimental procedures. Such identifications neither imply recommendation or endorsement by the National Institute of Standards and Technology nor does it imply that the material or equipment identified is the best available for the purpose. The authors declare no competing financial interest.
Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/6/4
Y1 - 2019/6/4
N2 - Hydrogen-deuterium exchange mass spectrometry (HDX-MS) is an established, powerful tool for investigating protein-ligand interactions, protein folding, and protein dynamics. However, HDX-MS is still an emergent tool for quality control of biopharmaceuticals and for establishing dynamic similarity between a biosimilar and an innovator therapeutic. Because industry will conduct quality control and similarity measurements over a product lifetime and in multiple locations, an understanding of HDX-MS reproducibility is critical. To determine the reproducibility of continuous-labeling, bottom-up HDX-MS measurements, the present interlaboratory comparison project evaluated deuterium uptake data from the Fab fragment of NISTmAb reference material (PDB: 5K8A) from 15 laboratories. Laboratories reported ∼89 800 centroid measurements for 430 proteolytic peptide sequences of the Fab fragment (∼78 900 centroids), giving ∼100% coverage, and ∼10 900 centroid measurements for 77 peptide sequences of the Fc fragment. Nearly half of peptide sequences are unique to the reporting laboratory, and only two sequences are reported by all laboratories. The majority of the laboratories (87%) exhibited centroid mass laboratory repeatability precisions of sLab»≤ (0.15 ± 0.01) Da (1σ). All laboratories achieved sLab»≤ 0.4 Da. For immersions of protein at THDX = (3.6 to 25) °C and for D2O exchange times of tHDX = (30 s to 4 h) the reproducibility of back-exchange corrected, deuterium uptake measurements for the 15 laboratories is σreproducibility15 Laboratories(tHDX) = (9.0 ± 0.9) % (1σ). A nine laboratory cohort that immersed samples at THDX = 25 °C exhibited reproducibility of σreproducibility25C cohort(tHDX) = (6.5 ± 0.6) % for back-exchange corrected, deuterium uptake measurements.
AB - Hydrogen-deuterium exchange mass spectrometry (HDX-MS) is an established, powerful tool for investigating protein-ligand interactions, protein folding, and protein dynamics. However, HDX-MS is still an emergent tool for quality control of biopharmaceuticals and for establishing dynamic similarity between a biosimilar and an innovator therapeutic. Because industry will conduct quality control and similarity measurements over a product lifetime and in multiple locations, an understanding of HDX-MS reproducibility is critical. To determine the reproducibility of continuous-labeling, bottom-up HDX-MS measurements, the present interlaboratory comparison project evaluated deuterium uptake data from the Fab fragment of NISTmAb reference material (PDB: 5K8A) from 15 laboratories. Laboratories reported ∼89 800 centroid measurements for 430 proteolytic peptide sequences of the Fab fragment (∼78 900 centroids), giving ∼100% coverage, and ∼10 900 centroid measurements for 77 peptide sequences of the Fc fragment. Nearly half of peptide sequences are unique to the reporting laboratory, and only two sequences are reported by all laboratories. The majority of the laboratories (87%) exhibited centroid mass laboratory repeatability precisions of sLab»≤ (0.15 ± 0.01) Da (1σ). All laboratories achieved sLab»≤ 0.4 Da. For immersions of protein at THDX = (3.6 to 25) °C and for D2O exchange times of tHDX = (30 s to 4 h) the reproducibility of back-exchange corrected, deuterium uptake measurements for the 15 laboratories is σreproducibility15 Laboratories(tHDX) = (9.0 ± 0.9) % (1σ). A nine laboratory cohort that immersed samples at THDX = 25 °C exhibited reproducibility of σreproducibility25C cohort(tHDX) = (6.5 ± 0.6) % for back-exchange corrected, deuterium uptake measurements.
UR - http://www.scopus.com/inward/record.url?scp=85066801766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066801766&partnerID=8YFLogxK
U2 - 10.1021/acs.analchem.9b01100
DO - 10.1021/acs.analchem.9b01100
M3 - Article
C2 - 31045344
AN - SCOPUS:85066801766
SN - 0003-2700
VL - 91
SP - 7336
EP - 7345
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 11
ER -